MENU
MGX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Metagenomi Therapeutics (MGX) Earnings Date & Reports
Metagenomi Therapeutics Inc is an vivo genome editing company capitalizing on its proprietary technologies to create curative genetic medicines for patients... Show more
A.I. Advisor
published Earnings
MGX is expected to report earnings to rise 1.37% to -74 cents per share on November 10
Q3'26
Est.
$-0.74
Q2'26
Beat
by $0.05
Q1'26
Beat
by $0.17
Q4'25
Beat
by $0.22
Q3'25
Beat
by $0.25
The last earnings report on August 10 showed earnings per share of -73 cents, beating the estimate of -77 cents. With 18.75K shares outstanding, the current market capitalization sits at 31.31M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Industry
N/A
Address
5959 Horton Street
Phone
+1 510 871-4880
Employees
119
Web
https://metagenomi.co